Author

Sandra K. Johnston

University of WashingtonORCID 0000-0003-4106-3924Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:Bayesian inference· 1 Research Focus:benchmarking· 1 Research Focus:cell type annotation· 1 Assay:clinical cohort / trial· 1 Research Focus:clustering· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1

Frequent Co-Authors

Kristin R. SwansoniD· 2 shared Alyx B. Porter· 1 shared Andrea Hawkins-Daarud· 1 shared Andrea J. Hawkins-DaarudiD· 1 shared Jann N. Sarkaria· 1 shared Kathleen M. Egan· 1 shared Lei Wang· 1 shared Leland S. Hu· 1 shared

Activity by Year

2018-2019 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioinformatics

Kristin R. SwansonORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsJCO Clinical Cancer InformaticsPeer-reviewedFeb 13, 2019

Quantifying Uncertainty and Robustness in a Biomathematical Model Based Patient-Specific Response Metric for Glioblastoma

Andrea J. Hawkins-Daarud, Sandra K. Johnston, Kristin R. Swanson

The paper develops a Bayesian framework to quantify uncertainty in a glioblastoma treatment response metric, showing robustness across a range of cutoff values for predicting time to progression.

37 citations

humanimaging

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 4, 2018

ENvironmental Dynamics Underlying Responsive Extreme Survivors (ENDURES) of Glioblastoma: a Multi-disciplinary Team-based, Multifactorial Analytical Approach

Sandra K. Johnston, Paula Whitmire, Susan Christine Massey…·Kristin R. Swanson

The paper introduces the ENDURES consortium to study extreme survivors of glioblastoma by integrating clinical data and creating patient-specific tumor models.

DOI 10.1101/461236

humanclinical cohort / trial

𝕏 PostBluesky